Response to the Comments on "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG1305 (PROBE study)"
- PMID: 33914487
- DOI: 10.1097/SLA.0000000000004824
Response to the Comments on "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG1305 (PROBE study)"
Conflict of interest statement
The authors report no conflicts of interest.
Comment on
-
A Prospective, Single-arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE Study).Ann Surg. 2022 Jul 1;276(1):140-145. doi: 10.1097/SLA.0000000000004494. Epub 2020 Sep 15. Ann Surg. 2022. PMID: 32941273
-
Comments On "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed By Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE study)" Ann Surg 2020 [Epub ahead of print]. DOI: 10.1097/SLA.0000000000004494.Ann Surg. 2021 Dec 1;274(6):e878-e879. doi: 10.1097/SLA.0000000000004822. Ann Surg. 2021. PMID: 33605596 No abstract available.
References
-
- Ishibe A, Watanabe J, Suwa Y, et al. A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG 1305 (PROBE study). Ann Surg 2020.
-
- Chudner A, Gachabayov M, Dyatlov A, et al. The influence of diverting loop ileostomy vs. colostomy on postoperative morbidity in restorative anterior resection for rectal cancer: a systematic review and meta-analysis. Langenbecks Arch Surg 2019; 404:129–139.
-
- Gavriilidis P, Azoulay D, Taflampas P. Loop transverse colostomy versus loop ileostomy for defunctioning of colorectal anastomosis: a systematic review, updated conventional meta-analysis, and cumulative meta-analysis. Surg Today 2019; 49:108–117.
-
- Seymour MT, Morton D. FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer. J Clin Oncol 2019; 37: (15 suppl): 3504-.
-
- Bertagnolli MM, Redston M, Compton CC, et al. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer—a study of CALGB 9581 and 89803. J Clin Oncol 2011; 29:3153–3162.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
